Literature DB >> 17452165

Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value.

Marco Guazzi1, Ross Arena, Aniello Ascione, Massimo Piepoli, Maurizio D Guazzi.   

Abstract

BACKGROUND: Increased slope of exercise ventilation to carbon dioxide production (VE/VCO2) is an established prognosticator in patients with heart failure. Recently, the occurrence of exercise oscillatory breathing (EOB) has emerged as an additional strong indicator of survival.
OBJECTIVE: The aim of this study is to define the respective prognostic significance of these variables and whether excess risk may be identified when either respiratory disorder is present.
METHODS: In 288 stable chronic HF patients (average left ventricular ejection fraction, 33 +/- 13%) who underwent cardiopulmonary exercise testing, the prognostic relevance of VE/VCO2 slope, EOB, and peak VO2 was evaluated by multivariate Cox regression.
RESULTS: During a mean interval of 28 +/- 13 months, 62 patients died of cardiac reasons. Thirty-five percent presented with EOB. Among patients exhibiting EOB, 54% had an elevated VE/VCO2 slope. The optimal threshold value for the VE/VCO2 slope identified by receiver operating characteristic analysis was < 36.2 or > or = 36.2 (sensitivity, 77%; specificity, 64%; P < .001). Univariate predictors of death included low left ventricular ejection fraction, low peak VO2, high VE/VCO2 slope, and EOB presence. Multivariate analysis selected EOB as the strongest predictor (chi2, 46.5; P < .001). The VE/VCO2 slope (threshold, < 36.2 or > or = 36.2) was the only other exercise test variable retained in the regression (residual chi2, 5.9; P = .02). The hazard ratio for subjects with EOB and a VE/VCO2 slope > or = 36.2 was 11.4 (95% confidence interval, 4.9-26.5; P < .001).
CONCLUSION: These findings identify EOB as a strong survival predictor even more powerful than VE/VCO2 slope. Exercise oscillatory breathing presence does not necessarily imply an elevated VE/VCO2 slope, but combination of either both yields to a burden of risk remarkably high.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452165     DOI: 10.1016/j.ahj.2007.02.034

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

Review 1.  The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review.

Authors:  Ross Arena; Jonathan Myers; Marco Guazzi
Journal:  Heart Fail Rev       Date:  2007-11-07       Impact factor: 4.214

Review 2.  Abnormalities in cardiopulmonary exercise testing ventilatory parameters in heart failure: pathophysiology and clinical usefulness.

Authors:  Marco Guazzi
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 3.  Altered breathing syndrome in heart failure: newer insights and treatment options.

Authors:  Yasuhiro Tomita; Takatoshi Kasai; Tomohiko Kisaka; Harry B Rossiter; Yasuki Kihara; Karlman Wasserman; Hiroyuki Daida
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 4.  A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure.

Authors:  Lawrence P Cahalin; Paul Chase; Ross Arena; Jonathan Myers; Daniel Bensimhon; Mary Ann Peberdy; Euan Ashley; Erin West; Daniel E Forman; Sherry Pinkstaff; Carl J Lavie; Marco Guazzi
Journal:  Heart Fail Rev       Date:  2013-01       Impact factor: 4.214

Review 5.  Exercise oscillatory ventilation: Mechanisms and prognostic significance.

Authors:  Bishnu P Dhakal; Gregory D Lewis
Journal:  World J Cardiol       Date:  2016-03-26

6.  Contemporary insights and novel treatment approaches to central sleep apnea syndrome in heart failure.

Authors:  Ryan L Grayburn; Yaquta Kaka; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-07

7.  Association of Oscillatory Ventilation during Cardiopulmonary Test to Clinical and Functional Variables of Chronic Heart Failure Patients.

Authors:  Hugo Valverde Reis; Priscila Abreu Sperandio; Clynton Lourenço Correa; Solange Guizilini; José Alberto Neder; Audrey Borghi-Silva; Michel Silva Reis
Journal:  Braz J Cardiovasc Surg       Date:  2018 Mar-Apr

8.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

9.  Invasive Hemodynamic and Metabolic Evaluation of HFpEF.

Authors:  J Emanuel Finet; Erik H Van Iterson; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-03-26

10.  Lungs in heart failure.

Authors:  Anna Apostolo; Giuliano Giusti; Paola Gargiulo; Maurizio Bussotti; Piergiuseppe Agostoni
Journal:  Pulm Med       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.